Yousif Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
GA
WCM
AIP
AP
Yousif Capital Management's REGN Position: Q2 2026 in Review
Yousif Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 6.4% in Q2 2026, selling an estimated $408K and leaving 8,798 shares worth $5.49M. The position accounts for 0.06% of the portfolio, ranked #293.
Yousif Capital Management first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $13M in Q3 2024. 279 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Yousif Capital Management held 8,798 shares of Regeneron Pharmaceuticals worth $5.49M as of Q2 2026.
- Yousif Capital Management sold 600 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $408K.
- Regeneron Pharmaceuticals made up 0.06% of Yousif Capital Management's portfolio in Q2 2026, its #293 holding.
- Yousif Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Yousif Capital Management's Regeneron Pharmaceuticals position peaked at $13M in Q3 2024.
- 279 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.